Literature DB >> 3942779

The high lipid content of respiratory mucins in cystic fibrosis is related to infection.

N Houdret, J M Perini, C Galabert, A Scharfman, P Humbert, G Lamblin, P Roussel.   

Abstract

Seven human bronchial mucins secreted by patients suffering from chronic bronchitis or from cystic fibrosis were prepared by exclusion from a Sepharose CL-2B column in 6 M guanidinium chloride. Their behaviour in CsBr density gradient centrifugation was compared. The mucin fractions were associated with peptides and lipids, the abundance of which decreases with the buoyant density. The lipid content of the mucin fractions appears to be related to the infectious character of the bronchial secretion and seems to be independent of cystic fibrosis. The content of fatty acids remaining after delipidation of mucin fractions from patients with chronic bronchitis or with cystic fibrosis also appears to be related more to the purulent character of the sputum than to cystic fibrosis or chronic bronchitis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3942779     DOI: 10.1016/0304-4165(86)90119-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

1.  Peptides of human bronchial mucus glycoproteins. Size determination by electron microscopy and by biosynthetic experiments.

Authors:  T Marianne; J M Perini; J J Lafitte; N Houdret; F R Pruvot; G Lamblin; H S Slayter; P Roussel
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

2.  Benzyl-N-acetyl-alpha-D-galactosaminide inhibits the sialylation and the secretion of mucins by a mucin secreting HT-29 cell subpopulation.

Authors:  P Delannoy; I Kim; N Emery; C De Bolos; A Verbert; P Degand; G Huet
Journal:  Glycoconj J       Date:  1996-10       Impact factor: 2.916

Review 3.  Clinical pharmacology of antibiotics and other drugs in cystic fibrosis.

Authors:  J Prandota
Journal:  Drugs       Date:  1988-05       Impact factor: 9.546

Review 4.  Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis.

Authors:  G Lamblin; S Degroote; J M Perini; P Delmotte; A Scharfman; M Davril; J M Lo-Guidice; N Houdret; V Dumur; A Klein; P Rousse
Journal:  Glycoconj J       Date:  2001-09       Impact factor: 2.916

5.  O-glycan variability of egg-jelly mucins from Xenopus laevis: characterization of four phenotypes that differ by the terminal glycosylation of their mucins.

Authors:  Y Guerardel; O Kol; E Maes; T Lefebvre; B Boilly; M Davril; G Strecker
Journal:  Biochem J       Date:  2000-12-01       Impact factor: 3.857

6.  Pseudomonas aeruginosa outer membrane adhesins for human respiratory mucus glycoproteins.

Authors:  C Carnoy; A Scharfman; E Van Brussel; G Lamblin; R Ramphal; P Roussel
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

7.  Differences in adhesion of Pseudomonas aeruginosa to mucin glycopeptides from sputa of patients with cystic fibrosis and chronic bronchitis.

Authors:  R Ramphal; N Houdret; L Koo; G Lamblin; P Roussel
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

8.  Secretion of Proteases by an Opportunistic Fungal Pathogen Scedosporium aurantiacum.

Authors:  Zhiping Han; Liisa Kautto; Helena Nevalainen
Journal:  PLoS One       Date:  2017-01-06       Impact factor: 3.240

Review 9.  Extracellular barriers in respiratory gene therapy.

Authors:  Niek Sanders; Carsten Rudolph; Kevin Braeckmans; Stefaan C De Smedt; Joseph Demeester
Journal:  Adv Drug Deliv Rev       Date:  2008-12-24       Impact factor: 15.470

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.